ACB $1.430 (1.42%)
ACNNF $0.030 (0%)
AERO $3.210 (0%)
ALEAF $0.050 (-14.97%)
AMMJ $0.048 (12.81%)
APHA $15.380 (0%)
ARNA $99.990 (0%)
ATT:CNX $0.080 (0%)
AUSA:CNX $0.065 (0%)
AUSAF $0.050 (0%)
AVXL $11.060 (-0.98%)
BAMM:CNX $0.130 (0%)
BBM:CNX $0.030 (-14.29%)
BBRRF $0.027 (-3.27%)
BE:CNX $0.005 (0%)
BIO:CNX $0.013 (0%)
BLIS:CNX $0.315 (0%)
BLO:CNX $0.395 (2.6%)
BLOZF $0.308 (2.5%)
BUDZ $0.100 (-9.09%)
CADMF $0.052 (0%)
CALI:CNX $0.085 (13.33%)
CANN $0.230 (-2.13%)
CARA $9.060 (-6.69%)
CBWTF $0.062 (0.16%)
CGC $2.540 (-0.97%)
CGRW $0.016 (-22%)
CHOO:CNX $0.005 (0%)
CHOOF $0.003 (-16%)
CNBX $3.990 (0%)
CNGGF $0.203 (0%)
CODI $22.680 (0.22%)
CPMD $0.020 (-4.81%)
CRBP $0.281 (0.07%)
CRON $3.050 (0.33%)
CROP:CNX $0.015 (0%)
CSI:CNX $0.070 (-12.5%)
CURR $0.349 (2.65%)
CVSI $0.033 (7.49%)
DIGP $0.014 (0%)
EEVVF $0.078 (0%)
EMHTF $0.039 (10.17%)
EPWCF $0.059 (0%)
FFT:CNX $0.040 (0%)
FNNZF $0.075 (13.64%)
GNBT $0.001 (0%)
GRIN:CNX $0.075 (-16.67%)
GRWG $4.840 (-1.83%)
GTBIF $10.150 (-1.46%)
GTII:CNX $13.090 (-1.65%)
GWPH $218.960 (0%)
HEXO $0.196 (-0.56%)
HHPHF $0.079 (0%)
HLSPY $0.363 (0%)
HMLSF $2.800 (0%)
HMPPF $0.498 (0%)
HRVOF $0.023 (-11.07%)
HSTRF $0.135 (0%)
HUGE:CNX $1.180 (-1.67%)
IAN:CNX $0.075 (0%)
IGC $0.520 (-3.02%)
IGXT $0.219 (13.76%)
IIPR $92.910 (-2.5%)
INQD $0.009 (-3.23%)
IONC:CNX $0.005 (0%)
IONKF $0.005 (-2.04%)
ISOL:CNX $0.035 (0%)
ITHUF $0.062 (5.65%)
KBEV:CNX $0.045 (0%)
KHRNF $0.091 (-2.15%)
KSHB $0.695 (0%)
LHS:CNX $1.470 (0%)
LHSIF $1.145 (0%)
LXX:CNX $8.400 (0%)
MCIG $0.028 (0%)
MEDIF $0.057 (1.15%)
MGWFF $0.060 (9.57%)
MJ:CNX $0.050 (0%)
MJNA $0.015 (1.4%)
MNTR $0.040 (0%)
MYM:CNX $0.140 (0%)
MYMMF $0.106 (0%)
NCNNF $0.058 (0%)
NDVAF $0.111 (-6.17%)
NGW:CNX $0.410 (0%)
NRXCF $0.035 (0%)
NSPDF $0.010 (-23.53%)
NVTQF $0.596 (0%)
NWKRF $0.424 (0%)
NXGWF $0.316 (0%)
NXTTF $0.033 (6.61%)
OH:CNX $5.330 (0%)
ORHOF $4.050 (0%)
PHCG $0.001 (0%)
PHVAF $0.038 (0%)
PILL:CNX $0.230 (-17.86%)
PKG:CNX $0.020 (-20%)
PLPRF $0.357 (0%)
PLUS:CNX $0.440 (0%)
PMCB $2.420 (0%)
PNPL $0.012 (0%)
PTNYF $0.018 (3.24%)
QCA:CNX $0.095 (-5%)
RDDTF $0.020 (1.53%)
RLLVF $0.001 (0%)
RMHB $0.028 (2.8%)
RQB:CNX $0.005 (0%)
RQHTF $0.448 (2.99%)
SLNG:CNX $0.095 (-9.52%)
SMG $83.180 (-1.21%)
SNN:CNX $0.155 (0%)
SOL:CNX $0.320 (0%)
SOLCF $0.250 (0%)
SPLIF $0.016 (-15.79%)
SPRWF $0.268 (0%)
STEM:CNX $0.035 (0%)
STMH $0.028 (1.45%)
SUN:CNX $0.150 (0%)
TBPMF $0.052 (3.82%)
TCAN:CNX $0.135 (0%)
TCNAF $0.080 (0%)
TER:CNX $3.480 (-0.57%)
TGEN $1.200 (0%)
TGIF:CNX $0.025 (-16.67%)
TGIFF $0.020 (-12.28%)
THC:CNX $0.048 (0%)
THCBF $0.044 (12.85%)
TLRY $3.540 (1.14%)
TRLFF $0.035 (0%)
TRSSF $2.710 (0.37%)
TURV $0.001 (0%)
VIDA:CNX $0.055 (0%)
VIN:CNX $0.015 (0%)
VPRB $0.047 (-6%)
VRTHF $0.026 (0%)
VVCIF $0.035 (-8.14%)
WAYL:CNX $0.740 (0%)
XXII $1.740 (-12.12%)
ZDPY $0.740 (-2.63%)
ZYNE $1.190 (-0.83%)
As 2016 continues to unfold, Canopy Growth Corporation (CGC.V) (TWMJF: OTC) has continued to prove itself as the leader in the Canadian medical marijuana industry.Investment Thesis We view Canopy as the top investment in the Canadian cannabis industry due to the following reasons: 1) The company continues to increase market…
MassRoots (MSRT) is one of the largest and most active technology platforms for cannabis consumers, businesses and activists with over 775,000 users. After MSRT completed a $1.4+ million capital raise late last week, we believe the company now meets all Nasdaq listing requirement and we expect to see an S-1 filed…
After GW Pharmaceuticals (GWPH) reported overwhelmingly positive results from its first Phase 3 study on its Epidiolex product, several cannabis stocks rallied and we think this is just the start of something big.Our rationale is based off of GWPH proving that cannabis should not be labeled as Schedule I substance.…
GW Pharmaceuticals plc (GWPH) just changed the game…Shares of GW Pharmaceuticals plc (GWPH) are up over 100% after announcing positive results for the first Phase 3 Clinical study for its Epidiolex product (for the treatment of Dravet syndrome).In this study, Epidiolex achieved the primary endpoint of a significant reduction in…